Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-26

Clinical Trial Update: A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma

View source ↗

Summary

A clinical trial update describing a novel serological risk model for early, non-invasive diagnosis of cholangiocarcinoma, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Cholangiocarcinoma | Status: NOT_YET_RECRUITING